UK Markets closed

Biophytis S.A. (BPTS)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.1600-0.2800 (-19.44%)
At close: 03:50PM EDT
1.1600 0.00 (0.00%)
After hours: 06:05PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.19
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 313.1700
52-week low 30.9988
50-day moving average 32.0317
200-day moving average 35.1252

Share statistics

Avg vol (3-month) 312.21k
Avg vol (10-day) 32.82k
Shares outstanding 512.9M
Implied shares outstanding 6N/A
Float 813.72M
% held by insiders 10.00%
% held by institutions 12.06%
Shares short (28 Apr 2022) 46.34k
Short ratio (28 Apr 2022) 40.25
Short % of float (28 Apr 2022) 4N/A
Short % of shares outstanding (28 Apr 2022) 40.04%
Shares short (prior month 30 Mar 2022) 46.62k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-52.81%
Return on equity (ttm)-783.82%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -26.57M
Net income avi to common (ttm)-31.25M
Diluted EPS (ttm)-2.9600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)23.93M
Total cash per share (mrq)1.71
Total debt (mrq)18.66M
Total debt/equity (mrq)327.13
Current ratio (mrq)1.37
Book value per share (mrq)0.54

Cash flow statement

Operating cash flow (ttm)-23.8M
Levered free cash flow (ttm)-14.6M